Discontinued — last reported Q4 '25
UnitedHealth Group D&A decreased by 7.9% to $1.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.0%, from $1.06B to $1.03B. Over 4 years (FY 2021 to FY 2025), D&A shows an upward trend with a 8.9% CAGR.
Higher levels typically reflect significant historical capital expenditures or acquisitions that are now being expensed over time.
This metric represents the non-cash accounting charges used to allocate the cost of tangible assets and intangible asset...
Capital-intensive hardware manufacturers generally show higher D&A relative to revenue than pure-play software companies.
depreciation_and_amortization_cf| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $778.00M | $796.00M | $771.00M | $788.00M | $802.00M | $828.00M | $982.00M | $970.00M | $1.02B | $1.01B | $974.00M | $997.00M | $1.02B | $1.04B | $1.04B | $1.06B | $1.08B | $1.10B | $1.12B | $1.03B |
| QoQ Change | — | +2.3% | -3.1% | +2.2% | +1.8% | +3.2% | +18.6% | -1.2% | +5.3% | -1.4% | -3.3% | +2.4% | +2.3% | +2.1% | +0.0% | +1.9% | +2.2% | +1.4% | +1.6% | -7.9% |
| YoY Change | — | — | — | — | +3.1% | +4.0% | +27.4% | +23.1% | +27.3% | +21.6% | -0.8% | +2.8% | -0.1% | +3.4% | +6.9% | +6.4% | +6.3% | +5.6% | +7.3% | -3.0% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| UnitedHealthcare | $221.00M | $217.00M | $216.00M | $219.00M | $221.00M | $221.00M | $222.00M | $218.00M |
| Optum Health | $277.00M | $283.00M | $291.00M | — | — | — | $319.00M | — |
| Optum Insight | $316.00M | $332.00M | $336.00M | — | — | — | $368.00M | — |
| Optum Rx | $206.00M | $209.00M | $198.00M | — | — | — | $208.00M | — |
| Total | $1.02B | $1.04B | $1.04B | $1.06B | $1.08B | $1.10B | $1.12B | $1.03B |